S. L. Hauser and D. S. Goodin, Multiple Sclerosis and Other Demyelinating Diseases

C. M. Poser, New diagnostic criteria for multiple sclerosis: guidelines for research protocols, Ann. Neurol, vol.13, pp.227-231, 1983.

A. J. Thompson, Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria, Lancet Neurol, vol.17, pp.162-173, 2018.

E. Leray, T. Moreau, A. Fromont, and G. Edan, Epidemiology of multiple sclerosis, Rev. Neurol, vol.172, pp.3-13, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01255824

A. Fromont, Geographic variations of multiple sclerosis in France, Brain, vol.133, pp.1889-1899, 2010.

, Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study, Lancet Neurol, vol.18, pp.269-285, 2016.

A. Ascherio, Environmental factors in multiple sclerosis, Expert Rev. Neurother, vol.13, pp.3-9, 2013.

F. D. Lublin and S. C. Reingold, Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis, Neurology, vol.46, pp.907-911, 1996.

F. D. Lublin, Defining the clinical course of multiple sclerosis: the 2013 revisions, Neurology, vol.83, pp.278-286, 2014.

D. T. Okuda, Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome, Neurology, vol.72, pp.800-805, 2009.

F. Barkhof, Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis, Brain, vol.120, pp.2059-2069, 1997.

C. Lebrun, F. Blanc, D. Brassat, H. Zephir, and J. De-seze, Cognitive function in radiologically isolated syndrome, Mult. Scler. J, vol.16, pp.919-925, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00617782

M. G. Inc, Characteristics of Radiologically isolated syndrome (RIS) national

C. Lebrun-frenay, , p.1, 2019.

D. H. Miller, D. T. Chard, and O. Ciccarelli, Clinically isolated syndromes. Lancet Neurol, vol.11, pp.157-169, 2012.

L. K. Fisniku, Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis, Brain, vol.131, pp.808-817, 2008.

M. Eriksson, O. Andersen, and B. Runmarker, Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis, Mult. Scler. J, vol.9, pp.260-274, 2003.

É. Thouvenot, Update on clinically isolated syndrome
URL : https://hal.archives-ouvertes.fr/hal-01934891

S. L. Hauser, Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS, Am. J. Ophthalmol, vol.130, pp.690-691, 2000.

H. F. Harbo, Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis, Mult. Scler. Houndmills Basingstoke Engl, vol.20, pp.660-668, 2014.

L. Kappos, The 11-year long-term follow-up study from the randomized BENEFIT CIS trial, Neurology, vol.87, pp.978-987, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-01576482

M. G. Inc, A comparative analysis of diagnosis delays when applying the, Salimata Gassama, 2017.

W. I. Mcdonald, Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis, Ann. Neurol, vol.50, pp.121-127, 2001.

D. H. Miller, Differential diagnosis of suspected multiple sclerosis: a consensus approach, Mult. Scler. Houndmills Basingstoke Engl, vol.14, pp.1157-1174, 2008.

P. Labauge, Critères diagnostiques de la sclérose en plaques

C. H. Polman, Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Ann. Neurol, vol.69, pp.292-302, 2011.

D. H. Miller and S. M. Leary, Primary-progressive multiple sclerosis, Lancet Neurol, vol.6, pp.903-912, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01880998

E. Leray, Evidence for a two-stage disability progression in multiple sclerosis, Brain, vol.133, pp.1900-1913, 2010.

X. Montalban, Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01793440

D. H. Mahad, B. D. Trapp, and H. Lassmann, Pathological mechanisms in progressive multiple sclerosis, Lancet Neurol, vol.14, pp.183-193, 2015.

J. R. Miller, A. M. Burke, and C. T. Bever, Occurrence of oligoclonal bands in multiple sclerosis and other CNS diseases, Ann. Neurol, vol.13, pp.53-58, 1983.

L. Moutsianas, Class II HLA interactions modulate genetic risk for multiple sclerosis, Nat. Genet, vol.47, pp.1107-1113, 2015.

, Experimental in vivo and in vitro models of multiple sclerosis: EAE and beyond

-. Pubmed, , p.10, 2019.

H. Lassmann, C. S. Raine, J. Antel, and J. W. Prineas, Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna, J. Neuroimmunol, vol.86, pp.213-217, 1998.

T. Kuhlmann, An updated histological classification system for multiple sclerosis lesions, Acta Neuropathol. (Berl.), vol.133, pp.13-24, 2017.

B. Bielekova, Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand, Nat. Med, vol.6, pp.1167-1175, 2000.

L. S. Madsen, A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor, Nat. Genet, vol.23, pp.343-347, 1999.

, Ome Sweet 'Omics -A Genealogical Treasury of Words

, Medicine, p.15, 2019.

K. A. Gandy, J. Zhang, P. Nagarkatti, and M. Nagarkatti, The role of gut microbiota in shaping the relapse-remitting and chronic-progressive forms of multiple sclerosis in mouse models, Sci. Rep, vol.9, p.6923, 2019.

E. A. Kabat, D. H. Moore, and H. Landow, AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS, J. Clin. Invest, vol.21, pp.571-577, 1942.

A. L. Greenfield and S. L. Hauser, B-cell Therapy for Multiple Sclerosis: Entering an era

, Ann. Neurol, vol.83, pp.13-26, 2018.

S. L. Hauser, B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis, N. Engl. J. Med, vol.358, pp.676-688, 2008.

,. Von-büdingen, A. Palanichamy, K. Lehmann-horn, B. A. Michel, and S. S. Zamvil,

, Update on the autoimmune pathology of multiple sclerosis: B cells as disease-drivers and therapeutic targets, Eur. Neurol, vol.73, pp.238-246, 2015.

P. Miossec and J. K. Kolls, Targeting IL-17 and TH17 cells in chronic inflammation, Nat. Rev. Drug Discov, vol.11, pp.763-776, 2012.

E. G. Kamburova, A single dose of rituximab does not deplete B cells in secondary lymphoid organs but alters phenotype and function, Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg, vol.13, pp.1503-1511, 2013.

A. Minagar and J. S. Alexander, Blood-brain barrier disruption in multiple sclerosis

. Scler, Houndmills Basingstoke Engl, vol.9, pp.540-549, 2003.

H. Takeuchi, Tumor necrosis factor-alpha induces neurotoxicity via glutamate release from hemichannels of activated microglia in an autocrine manner, J. Biol. Chem, vol.281, pp.21362-21368, 2006.

R. Yamasaki, Differential roles of microglia and monocytes in the inflamed central nervous system, J. Exp. Med, vol.211, pp.1533-1549, 2014.

C. J. Willer, Twin concordance and sibling recurrence rates in multiple sclerosis

, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.12877-12882, 2003.

T. Hansen, Concordance for multiple sclerosis in Danish twins: an update of a nationwide study, Mult. Scler. Houndmills Basingstoke Engl, vol.11, pp.504-510, 2005.

S. E. Baranzini, Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis, Nature, vol.464, pp.1351-1356, 2010.

N. P. Robertson, Age-adjusted recurrence risks for relatives of patients with multiple sclerosis, Brain J. Neurol, vol.119, issue.2, pp.449-455, 1996.

S. E. Baranzini and J. R. Oksenberg, The Genetics of Multiple Sclerosis: From 0 to

. Years, Trends Genet. TIG, vol.33, pp.960-970, 2017.

J. J. Cerqueira, Time matters in multiple sclerosis: can early treatment and long-term follow-up ensure everyone benefits from the latest advances in multiple sclerosis?, J. Neurol. Neurosurg. Psychiatry, vol.89, pp.844-850, 2018.

P. O'connor, Long-term safety and effectiveness of natalizumab redosing and treatment in the STRATA MS Study, Neurology, vol.83, pp.78-86, 2014.

R. A. Linker, B. C. Kieseier, and R. Gold, Identification and development of new therapeutics for multiple sclerosis, Trends Pharmacol. Sci, vol.29, pp.558-565, 2008.

X. Montalban, Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis, N. Engl. J. Med, vol.376, pp.209-220, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01793440

L. Kappos, Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study, The Lancet, vol.391, pp.1263-1273, 2018.

L. J. Balcer, Clinical outcome measures for research in multiple sclerosis

. Neuro-ophthalmol, Off. J. North Am. Neuro-Ophthalmol. Soc, vol.21, pp.296-301, 2001.

B. Nagler, Studies on the natural history of multiple sclerosis. 1. Design and diagnosis, Acta Neurol. Scand, vol.42, pp.141-156, 1966.

J. F. Kurtzke, On the evaluation of disability in multiple sclerosis, Neurology, vol.11, pp.686-694, 1961.

J. F. Kurtzke, Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, vol.33, pp.1444-1452, 1983.

R. Bove, Multiple sclerosis in men: management considerations, J. Neurol, vol.263, pp.1263-1273, 2016.

L. Pellegrino, M. Coscia, M. Muller, C. Solaro, and M. Casadio, Evaluating upper limb impairments in multiple sclerosis by exposure to different mechanical environments, Sci. Rep, vol.8, 2018.

J. Basmajian, Control and training of individual motor units, Science, vol.141, pp.440-441, 1963.

S. L. Pullman, D. S. Goodin, A. I. Marquinez, S. Tabbal, and M. Rubin, Clinical utility of surface EMG: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology, Neurology, vol.55, pp.171-177, 2000.

J. S. Hurwitz, A. Nugent, F. Halper, and M. Kaufman, Big Data For Dummies, 2013.

C. Lovis, Bigdata, artificial intelligence and blockchain for dummies, Rev. Med. Suisse, vol.14, pp.1559-1563, 2018.

A. Shirani, B. D. Newton, and D. T. Okuda, Finger tapping impairments are highly sensitive for evaluating upper motor neuron lesions, BMC Neurol, vol.17, 2017.

P. Feys, The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis, Mult. Scler. Houndmills Basingstoke Engl, vol.23, pp.711-720, 2017.

D. S. Goodin, A questionnaire to assess neurological impairment in multiple sclerosis

, Mult. Scler. Houndmills Basingstoke Engl, vol.4, pp.444-451, 1998.

, Current state of digital signal processing in myoelectric interfaces and related applications | Elsevier Enhanced Reader

S. J. Crenshaw, T. D. Royer, J. G. Richards, and D. J. Hudson, Gait variability in people with multiple sclerosis, Mult. Scler. Houndmills Basingstoke Engl, vol.12, pp.613-619, 2006.

L. Rusu, Analysis of foot and ankle disorders and prediction of gait in multiple sclerosis rehabilitation, Eur. J. Med. Res, vol.19, p.73, 2014.

M. G. Benedetti, Gait abnormalities in minimally impaired multiple sclerosis patients, Mult. Scler. Houndmills Basingstoke Engl, vol.5, pp.363-368, 1999.

J. A. Kent-braun, Strength, skeletal muscle composition, and enzyme activity in multiple sclerosis, J. Appl. Physiol. Bethesda Md, vol.83, 1985.

A. V. Ng, R. G. Miller, D. Gelinas, and J. A. Kent-braun, Functional relationships of central and peripheral muscle alterations in multiple sclerosis, Muscle Nerve, vol.29, pp.843-852, 2004.

C. L. Martin, Gait and balance impairment in early multiple sclerosis in the absence of clinical disability, Mult. Scler. Houndmills Basingstoke Engl, vol.12, pp.620-628, 2006.

G. Piaton, A. Williams, D. Seilhean, and C. Lubetzki,

. Prog, Brain Res, vol.175, pp.453-464, 2009.

M. S. Yeung, Dynamics of oligodendrocyte generation in multiple sclerosis, Nature, vol.566, pp.538-542, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02002274

A. Giorgio, Cortical functional reorganization and its relationship with brain structural damage in patients with benign multiple sclerosis, Mult. Scler. J, vol.16, pp.1326-1334, 2010.

M. A. Rocca, Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes, Lancet Neurol, vol.4, pp.618-626, 2005.

D. S. Peterson, G. Gera, F. B. Horak, and B. W. Fling, Supraspinal control of automatic postural responses in people with multiple sclerosis, Gait Posture, vol.47, pp.92-95, 2016.

D. S. Peterson and B. W. Fling, How changes in brain activity and connectivity are associated with motor performance in people with MS, NeuroImage Clin, vol.17, pp.153-162, 2018.